COMPANY
Inso Biosciences Inc.
NIH awards 2
- NIH contract (government contract; not a grant and not an investment round) 75N91022C00062-0-9999-1 FY2022: $399,674 awarded for that fiscal year; activity N43 (OTHER_NIH); PI BISOGNI, ADAM; recipient as written: INSO BIOSCIENCES INC, Ithaca, NY. SBIR TOPIC 43 source ↗
- NIH award 1R43AI157563-01 FY2021: $250,894 awarded for that fiscal year; activity R43 (SBIR); PI TIAN, HARVEY CHEN; recipient as written: INSO BIOSCIENCES INC, Ithaca, NY. Facile Method for Enhanced Pathogen Detectio source ↗
Funding and NIH signals
- SEC Form D raise Raised $750K in debt securities (Form D filed Apr 10, 2026). SEC Form D 0001906426-26-000003 (Apr 10, 2026)
Evidence (1 event)
- Apr 10, 2026 · SEC Form D 0001906426-26-000003
Name of Issuer: Inso Biosciences Inc.; CIK: 1906426; Address: Ithaca, NY; Submission type: D; Filing date: 2026-04-10; Industry Group: Biotechnology; Date of First Sale: 2026-03-03; Types of Securities Offered: Debt, Option/warrant, Security to be acquired, Other (Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be acquired upon such conversion.); Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 750000; Federal exemptions: 06b
- Apr 10, 2026 · SEC Form D 0001906426-26-000003